Acute Pancreatitis as an Initial Manifestation of Pediatric AML: A Case Report with Review of Literature

Abstract

Acute myeloid leukemia (AML) accounts for around 15 to 20% of childhood leukemia. Acute leukemia has variable presenting features and extramedullary manifestations typically occur in 10 to 20% of patients with AML, even before bone marrow involvement. Therefore, leukemia may get unnoticed if symptoms from other organs predominate. Acute pancreatitis, as an initial manifestation of acute leukemia, is seen commonly during and after the course of chemotherapy.

Here, we report the case of a 16-year-old female patient who presented with pain abdomen, multiple swellings in the neck, axilla, and breast for 2 months and had jaundice at presentation was diagnosed to be having acute pancreatitis with AML. Pancreatitis was resolved after starting cytoreductive chemotherapy. Hence, the causation of pancreatitis in the index case was likely due to pancreatic infiltration by the leukemic cells, unlike the common etiologies such as hypercalcemia and chemotherapy drugs seen in the setting of leukemia.

Keywords

acute myeloid leukemia - acute pancreatitis - case report - extramedullary

Authors' Contributions

The manuscript has been read and approved by all the authors and requirement for authorship of this document has been met. Each author believes that the manuscript represents honest work. T.S. and S.K.A. conceptualized the study. T.S., S.K.A., and A.H. helped in collection of data, searched literature, drafted the manuscript, and gave final approval for the same.

Patient Consent

Written informed consent has been taken from the parent/guardian.

Publication History

Article published online:
04 June 2025

• References

• 1 Tseng S, Lee ME, Lin PC. A review of childhood acute myeloid leukemia: diagnosis and novel treatment. Pharmaceuticals (Basel) 2023; 16 (11) 1614
• 2 Tebbi CK. Etiology of acute leukemia: a review. Cancers (Basel) 2021; 13 (09) 2256
• 3 de Rooij JD, Zwaan CM, van den Heuvel-Eibrink M. Pediatric AML: from biology to clinical management. J Clin Med 2015; 4 (01) 127-149
• 4 Fianchi L, Quattrone M, Criscuolo M. et al. Extramedullary involvement in acute myeloid leukemia. a single center ten years' experience. Mediterr J Hematol Infect Dis 2021; 13 (01) e2021030
• 5 Shah AS, Wilson DP. Primary hypertriglyceridemia in children and adolescents. J Clin Lipidol 2015; 9 (5, Suppl): S20-S28
• 6 Wolthers BO, Frandsen TL, Baruchel A. et al; Ponte di Legno Toxicity Working Group. Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study. Lancet Oncol 2017; 18 (09) 1238-1248
• 7 Teng HW, Bai LY, Chao TC, Wang WS, Chen PM. Acute pancreatitis during all-trans-retinoic acid treatment for acute promyelocytic leukemia in a patient without overt hypertriglyceridemia. Jpn J Clin Oncol 2005; 35 (02) 94-96
• 8 Aref S, El-Sherbiny M, Mabed M, Menessy A, El-Refaei M. Urokinase plasminogen activator receptor and soluble matrix metalloproteinase-9 in acute myeloid leukemia patients: a possible relation to disease invasion. Hematology 2003; 8 (06) 385-391
• 9 Yang WX, An K, Liu GF, Zhou HY, Gao JC. Acute pancreatitis as initial presentation of acute myeloid leukemia-M2 subtype: a case report. World J Clin Cases 2023; 11 (06) 1385-1392
• 10 Sumitani R, Hori T, Murai J. et al. Acute myeloid leukemia developing with acute pancreatitis mimicking autoimmune pancreatitis. Intern Med 2021; 60 (11) 1753-1757
• 11 Fukushima H, Morita K, Ikemura M. et al. Acute pancreatitis as the initial manifestation of acute myeloid leukemia with chromosome 16 rearrangements. Int J Hematol 2023; 118 (03) 381-387
• 12 Manju D, Kapoor DD, Dogra DV. et al. Acute pancreatitis as presenting complication of acute myeloid leukaemia (a rare case and literature review). J Current Med Res Opinion. 2019; 2 (12) 372-374